| Date Filed | Type | Description |
| 10/03/2023 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 2,447 options to buy
@ $11.24, valued at
$27.5k
|
|
| 07/05/2023 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 2,734 options to buy
@ $10.06, valued at
$27.5k
|
|
| 06/08/2023 |
4
| Kurzius Lawrence Erik (Chairman & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Gifted 486 shares
@ $0 |
|
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/27/2023 |
4
| Kurzius Lawrence Erik (Chairman & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Acquired 138 options to buy
@ $85.22, valued at
$11.8k
|
|
| 04/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/04/2023 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 2,926 options to buy
@ $9.4, valued at
$27.5k
|
|
| 03/31/2023 |
4
| Kurzius Lawrence Erik (Chairman, President & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Granted 222,223 options to buy
@ $81.79, valued at
$18.2M
|
|
| 03/17/2023 |
4
| Kurzius Lawrence Erik (Chairman, President & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Paid exercise price by delivering 3,663 shares
@ $71.78, valued at
$262.9k
Exercised 7,970 restricted stock units
@ $0 |
|
| 02/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/25/2023 |
4
| Kurzius Lawrence Erik (Chairman, President & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Granted 57,066 shares
@ $0
Acquired 131 options to buy
@ $84.57, valued at
$11k
Acquired 146 options to buy
@ $76.13, valued at
$11.1k
Acquired 139 options to buy
@ $84.61, valued at
$11.7k
|
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 695 options to buy
@ $13.19, valued at
$9.2k
|
|
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 739 options to buy
@ $12.41, valued at
$9.2k
|
|
| 09/02/2022 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 606 options to buy
@ $15.13, valued at
$9.2k
|
|
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 351 options to buy
@ $26.09, valued at
$9.2k
|
|
| 04/01/2022 |
4
| Kurzius Lawrence Erik (Chairman, President & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Granted 194,219 options to buy
@ $97.26, valued at
$18.9M
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 323 options to buy
@ $28.41, valued at
$9.2k
|
|
| 02/16/2022 |
SC 13D/A
| Kurzius Lawrence Erik reports a 7.5% stake in McCORMICK & COMPANY, INCORPORATED |
| 02/15/2022 |
4
| Kurzius Lawrence Erik (Chairman, President & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Paid exercise price by delivering 39,224 shares
@ $101.015, valued at
$4M
|
|
| 02/02/2022 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 352 options to buy
@ $26.04, valued at
$9.2k
|
|
| 02/01/2022 |
4
| Kurzius Lawrence Erik (Chairman, President & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Gifted 12,690 shares
@ $0
Sold 8,400 shares
@ $98, valued at
$823.2k
Sold 90,000 shares
@ $100.0851, valued at
$9M
Acquired 117 options to buy
@ $85.38, valued at
$10k
Acquired 124 options to buy
@ $81.06, valued at
$10k
Acquired 116 options to buy
@ $94.62, valued at
$11k
Exercised 8,400 options to buy
@ $35.55, valued at
$298.6k
Exercised 90,000 options to buy
@ $35.55, valued at
$3.2M
|
|
| 01/26/2022 |
4
| Kurzius Lawrence Erik (Chairman, President & CEO) has filed a Form 4 on MCCORMICK & CO INC|
Txns:
| Granted 81,208 shares
@ $0 |
|
| 01/04/2022 |
4
| Kurzius Lawrence Erik (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 323 options to buy
@ $28.38, valued at
$9.2k
|
|
|